CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880724208
- Phone
- 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale 10% owner sold 426,005 shares at $40.32 ($17,175,244)
- 4 Planned sale Chief Development Officer sold 20,225 shares at $39.99 ($808,844)
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Development Officer sold 19,865 shares at an average $35.03 ($695,823)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Development Officer sold 360 shares at $34.90 ($12,564)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Operating Officer sold 10,000 shares at an average $28.19 ($281,857)
- 144 Insider Sale of Securities
Page 4 of 13 · 253 filings